Nathaniel Calloway - Oct 28, 2022 Form 3 Insider Report for Anebulo Pharmaceuticals, Inc. (ANEB)

Role
Director
Signature
/s/ James R. Merchant, Attorney-in-Fact
Stock symbol
ANEB
Transactions as of
Oct 28, 2022
Transactions value $
$0
Form type
3
Date filed
11/2/2022, 04:26 PM
Next filing
Nov 2, 2022

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.